Ketamine Evolved
If you are suffering from depression, PTSD, other mood disorders or chronic pain, we invite you to explore Innovative Ketamine. The COVID-19 pandemic has amplified the mental health crisis in our country, but there is hope. IV Ketamine infusions have an 80 percent success rate and may be a lifeline for you or someone you love. Schedule a consult today to learn more.
Transforming Lives & Giving New Hope To Those Suffering From Depression & Pain
Ketamine for Depression
Your first treatment will be a discussion of your past medical history, a discussion of ketamine, going over treatment plan and goals, reviewing the risks and benefits of the procedure and answering all your questions. If you have insurance, we do accept insurance for this visit.
Patients typically receive a series of 6 infusions over the course of approximately two weeks for mood disorders. Each infusion typically lasts about 45-55 minutes. Most clinical trials have consistently shown a 70-75% success rate with this approach, however, based on our clinical experience, we are seeing an 80% success rate. The treatment does require booster infusions as time passes to keep the effect going and to keep patients symptom-free. These boosters are the same duration and are usually done once a month.
Ketamine for Pain
Generally, two types of patients with chronic pain may benefit from this medication: patients with chronic pain that have not had much success with other pain medications or treatments, and/or patients with chronic pain who plan to undergo surgery.
Several conditions, including cancer, CRPS, fibromyalgia, neuropathic pain, phantom pain, postherpetic neuralgia, sickle cell disease, and spinal injury, may result in chronic pain. Ketamine has been used to manage pain in all of these conditions. Multiple professional organizations, including the American Society of Regional Anesthesia and Pain Medicine (ASRA), the American Academy of Pain Medicine (AAPM), and the American Society of Anesthesiologists (ASA), have agreed that the collective evidence has shown support for ketamine’s role in managing pain for these conditions.
The pain protocol differs significantly than the protocol for depression or other mood disorders. For the pain protocol, the patient is given a 3 hour infusion of Ketamine. Also, the dosage is significantly higher than for the mood disorder protocol. Due to this increase in dosage, patients tend to get some more side-effects (nausea, dizziness, longer disassociation) compared to the depression protocol. This being said, our patients tend to do very well with our pain protocols.
Now Offering Spravato (Esketamine)
Spravato (aka Esketamine) is a new, FDA approved medication, which is an isomer of Ketamine (aka racemic ketamine).
Spravato is an FDA approved medication (it may be covered by insurance). However, we must use the medication exactly as the FDA approved it, thus there are restrictions on how it must be administered.